Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of David James
Introduction
David James is an accomplished inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of novel polymeric media for medical applications. His work focuses on improving the treatment of blood-related conditions through innovative technologies.
Latest Patents
David James holds a patent for "Crosslinked polysaccharide based absorbents for removal of anti-A and/or anti-B antibodies from human plasma and whole blood." This invention involves polymeric media based on modified natural polysaccharides designed to remove Anti-A and Anti-B antibodies from human blood or plasma. The media comprises a polymeric solid support with blood group A and/or B Antigen ligands attached, ensuring stability under physiological pH conditions.
Career Highlights
David is currently associated with Cytosorbents Corporation, where he applies his expertise in developing advanced medical technologies. His innovative approach has led to the creation of effective solutions for blood purification and antibody removal, which are crucial in various medical treatments.
Collaborations
David collaborates with talented professionals in his field, including Tamaz Guliashvili and Maryann Gruda. Their combined efforts contribute to the advancement of medical technologies and the development of new therapeutic solutions.
Conclusion
David James exemplifies the spirit of innovation in the biomedical field through his groundbreaking patent and contributions to Cytosorbents Corporation. His work continues to impact the medical community positively, paving the way for improved patient care and treatment options.